WO2007044982A3 - Methods for the preservation of platelet efficacy during storage - Google Patents

Methods for the preservation of platelet efficacy during storage Download PDF

Info

Publication number
WO2007044982A3
WO2007044982A3 PCT/US2006/040494 US2006040494W WO2007044982A3 WO 2007044982 A3 WO2007044982 A3 WO 2007044982A3 US 2006040494 W US2006040494 W US 2006040494W WO 2007044982 A3 WO2007044982 A3 WO 2007044982A3
Authority
WO
WIPO (PCT)
Prior art keywords
preservation
during storage
methods
efficacy during
platelet efficacy
Prior art date
Application number
PCT/US2006/040494
Other languages
French (fr)
Other versions
WO2007044982A2 (en
Inventor
Connie Lynn Erickson-Miller
Original Assignee
Smithkline Beecham Corp
Connie Lynn Erickson-Miller
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp, Connie Lynn Erickson-Miller filed Critical Smithkline Beecham Corp
Priority to EP06826085A priority Critical patent/EP1942906A2/en
Priority to JP2008535784A priority patent/JP2009511603A/en
Priority to US12/089,978 priority patent/US20080286865A1/en
Publication of WO2007044982A2 publication Critical patent/WO2007044982A2/en
Publication of WO2007044982A3 publication Critical patent/WO2007044982A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E60/00—Enabling technologies; Technologies with a potential or indirect contribution to GHG emissions mitigation
    • Y02E60/30—Hydrogen technology
    • Y02E60/36—Hydrogen production from non-carbon containing sources, e.g. by water electrolysis

Abstract

Invented is a method for the preservation of human platelet lifespan and/or efficacy during storage which comprises the addition of an effective amount of a non-peptide TPO receptor agonists to a storage solution containing human platelets.
PCT/US2006/040494 2005-10-13 2006-10-13 Methods for the preservation of platelet efficacy during storage WO2007044982A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP06826085A EP1942906A2 (en) 2005-10-13 2006-10-13 Methods for the preservation of platelet efficacy during storage
JP2008535784A JP2009511603A (en) 2005-10-13 2006-10-13 How to maintain the effectiveness of platelets during storage
US12/089,978 US20080286865A1 (en) 2005-10-13 2006-10-13 Methods for the Preservation of Platelet Efficacy During Storage

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72624905P 2005-10-13 2005-10-13
US60/726,249 2005-10-13

Publications (2)

Publication Number Publication Date
WO2007044982A2 WO2007044982A2 (en) 2007-04-19
WO2007044982A3 true WO2007044982A3 (en) 2009-04-30

Family

ID=37943597

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/040494 WO2007044982A2 (en) 2005-10-13 2006-10-13 Methods for the preservation of platelet efficacy during storage

Country Status (4)

Country Link
US (1) US20080286865A1 (en)
EP (1) EP1942906A2 (en)
JP (1) JP2009511603A (en)
WO (1) WO2007044982A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CY2010012I2 (en) * 2000-05-25 2020-05-29 Novartis Ag THROMBOPOIETIN MIMETICS
US20110129550A1 (en) 2007-02-16 2011-06-02 Connie Erickson-Miller Cancer treatment method
ECSP077628A (en) 2007-05-03 2008-12-30 Smithkline Beechman Corp NEW PHARMACEUTICAL COMPOSITION
WO2009048953A1 (en) * 2007-10-09 2009-04-16 The Trustees Of The University Of Pennsylvania Thrombopoietin receptor agonist (tpora) kills acute human myeloid leukemia cells
CN101481352A (en) * 2008-01-10 2009-07-15 上海恒瑞医药有限公司 Bicycle substituted pyrazolone azo derivative, preparation thereof and use in medicine

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5932546A (en) * 1996-10-04 1999-08-03 Glaxo Wellcome Inc. Peptides and compounds that bind to the thrombopoietin receptor
US6506362B1 (en) * 1995-06-07 2003-01-14 Glaxo Group Limited Labeled compounds that bind to a thrombopoietin receptor
US20040220140A1 (en) * 2003-02-24 2004-11-04 Marine Polymer Technologies, Inc. Cell-polymer fiber compositions and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2361260A1 (en) * 1999-01-28 2000-08-03 Saroj Vadhan-Raj Methods for increasing circulating platelets for collection and cryopreservation using thrombopoietin compositions
EP1207155A4 (en) * 1999-07-26 2005-01-12 Shionogi & Co Drug compositions exhibiting thrombopoietin agonism
TWI284639B (en) * 2000-01-24 2007-08-01 Shionogi & Co A compound having thrombopoietin receptor agonistic effect
CY2010012I2 (en) * 2000-05-25 2020-05-29 Novartis Ag THROMBOPOIETIN MIMETICS
WO2001092211A1 (en) * 2000-05-30 2001-12-06 Chugai Seiyaku Kabushiki Kaisha Compounds exhibiting thrombopoietin-like activities
CA2435143A1 (en) * 2001-01-26 2002-08-01 Shionogi & Co., Ltd. Halogen compounds having thrombopoietin receptor agonism
EP1361220A4 (en) * 2001-01-26 2005-09-07 Shionogi & Co Cyclic compounds having thrombopoietin receptor agonism
TWI280128B (en) * 2002-05-22 2007-05-01 Smithkline Beecham Corp 3'-[(2Z)-[1-(3,4- dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
TW200526638A (en) * 2003-10-22 2005-08-16 Smithkline Beecham Corp 2-(3,4-dimethylphenyl)-4-{[2-hydroxy-3'-(1H-tetrazol-5-yl)biphenyl-3-yl]-hydrazono}-5-methyl-2,4-dihydropyrazol-3-one choline

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6506362B1 (en) * 1995-06-07 2003-01-14 Glaxo Group Limited Labeled compounds that bind to a thrombopoietin receptor
US5932546A (en) * 1996-10-04 1999-08-03 Glaxo Wellcome Inc. Peptides and compounds that bind to the thrombopoietin receptor
US20040220140A1 (en) * 2003-02-24 2004-11-04 Marine Polymer Technologies, Inc. Cell-polymer fiber compositions and uses thereof

Also Published As

Publication number Publication date
US20080286865A1 (en) 2008-11-20
EP1942906A2 (en) 2008-07-16
WO2007044982A2 (en) 2007-04-19
JP2009511603A (en) 2009-03-19

Similar Documents

Publication Publication Date Title
WO2005039291A3 (en) Methods, compositions and devices for inducing stasis in cells
EP1757453A4 (en) Liquid storage body
DK1858575T3 (en) Package for medical device
EP1835803A4 (en) Composition for preserving platelets and method of using the same
SI1811998T1 (en) Triazoles useful as inhibitors of protein kinases
GB0709533D0 (en) Platelets from stem cells
WO2008107724A3 (en) Stabilisation of biological cell markers
EP1804794A4 (en) Spiropiperidine compounds useful as beta-secretase inhibitors for the treatment of alzhermer s disease
WO2007044982A3 (en) Methods for the preservation of platelet efficacy during storage
EP1905343A4 (en) Medical instrument storage device
GB0514597D0 (en) New fishing bait, and storage and packaging device for such bait
EP1863495A4 (en) Calcium salt of myo-inositol 1,6:2,3:4,5 tripyrophosphate as an allosteric effector of hemoglobin
EP1864641A4 (en) Package of freeze storage container and process for producing the same
WO2007003382A3 (en) Storage medium for cells
EP1749744A4 (en) Liquid storage part connected body
PL2249966T3 (en) Container for the preparation, preservation and storage of biological samples using a drying agent
AU2003221787A1 (en) Solution containing platelet activation inhibitors for pathogen reducing and storing blood platelets
AU2003219291A1 (en) Bicyclic compounds useful as angiotensin ii agonists
GB2431878B (en) Container of active substances
WO2006081337A3 (en) Erastin analogues and their uses for killing cancer cells
ZA200700751B (en) Azalndoles useful as inhibitors of protein kinases
AU2003272198A1 (en) Storage of blood
EP1809736A4 (en) Cryopreservation of cells
WO2005032341A3 (en) Methods of evaluating oocytes for storage or reproductive treatments
PL382812A1 (en) Application of plastic container containing non-organic addition

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: 2008535784

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 12089978

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2006826085

Country of ref document: EP